| Target |
Bispecific, Receptor tyrosine-protein kinase erbB-2, 2.7.10.1, Metastatic lymph node gene 19 protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340, ERBB2, HER2, MLN19, NEU, NGL, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T3E |
| Function |
InVivoMAb Anti-Human ERBB2/HER-2 & CD3e Bispecific Antibody (Iv0231)[Iv0231] (ARO-A12986) is amouse monoclonalantibody detectingBispecific, Receptor tyrosine-protein kinase erbB-2, 2.7.10.1, Metastatic lymph node gene 19 protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, CD340, ERBB2, HER2, MLN19, NEU, NGL, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T3EinFuncS. Suitable forHuman.HighlightsProtein A/G purified from cell culture supernatant.— Ensuring high specificity and minimal background.Validated for FuncS— Optimized for consistent performance. |
